Products | SPR Sensor chips | Data sheets

  Instructions for use


RG sensor chips

XanTec’s RGD200M sensor chips are coated with a bioinert carboxymethyl-dextran matrix derivatized with a 24-nt single-stranded DNA oligo sequence. This oligo is capable of binding ligands conjugated to the complementary DNA sequence via hybridization of the two DNA strands. While the captured ligand is bound stably under physiological conditions, complete regeneration of the chip can be achieved by denaturation of the double-stranded DNA at alkaline pH, liberating the surface-bound oligo for another capture cycle.

XanTec offers two variants for DNA-mediated, reversible ligand immobilization using the RGD200M sensor chip.

Variant 1: The RG biotin capture reagent RG-SA (streptavidin pre-conjugated with the complementary DNA oligo) is immobilized on the RGD200M sensor chip via DNA hybridization. A biotinylated ligand is then injected, binding streptavidin with high affinity and stability. Immobilization levels are controlled by ligand concentration and injection duration.

Variant 2: The ligand is functionalized with dibenzocyclooctyne (DBCO) using the XanTec DBCO Labeling Kit, desalted, and subsequently reacted with the RG-modifier DNA oligo via a selective Click reaction. The resulting DNA–ligand conjugate is directly immobilized on the RGD200M sensor chip through DNA hybridization, thereby eliminating the intermediate streptavidin capture step. Immobilization levels are controlled by ligand concentration and injection duration.

This approach can reduce nonspecific binding, lower diffusion limitations, enable higher capture densities, and facilitate surface regeneration, ultimately improving data quality while reducing assay setup time.

Key features:

Schematic illustration of an RGD200M sensor chip. Variant 1 (left): Streptavidin (purple), pre-conjugated with the complementary DNA oligo, is immobilized on the RGD200M sensor chip via hybridization with the surface-bound single-stranded DNA oligo (orange). In a subsequent capture step, the immobilized streptavidin binds biotinylated ligands (yellow). Variant 2 (right): The ligand is pre-conjugated with the complementary DNA oligo and directly immobilized on the RGD200M sensor chip via hybridization with the surface-bound single-stranded DNA oligo. The decaying red gradient represents the evanescent field.1
Product code RGD200M
Base coating 3D, 200 nm bioinert CM-dextran (medium density)
Variant Variant 1: RG-SA Variant 2: RG-Modifier
Capture immobilization capacity [µRIU] ≈ 3,5002 ≈ 5,0003
Recommended ligands biotinylated proteins or peptides proteins or peptides possessing an NHS-reactive amino group
Recommended analytes
  • proteins
  • peptides
  • proteins
  • peptides
  • small molecules
Intended purpose
  • kinetic and equilibrium analyses of medium analytes
  • assay development with new or uncharacterized binding partners
  • screening of biotinylated peptide and protein libraries
  • time-critical SPR experiments where rapid setup is required
  • biological systems that are difficult to regenerate
  • not recommended for biomolecules containing DNA-binding motifs or intercalating properties
  • kinetic and equilibrium analyses of small, medium, and large analytes
  • systems requiring higher ligand immobilization densities than achievable with the RG-SA variant
  • biological systems demanding superior baseline stability
  • applications involving ligands or analytes that are difficult to regenerate
  • not recommended for biomolecules containing DNA-binding motifs or intercalating properties

1 All illustrations are schematic representations and are not drawn to scale; dimensions, densities, and spatial relationships do not reflect actual physical or chemical proportions.

2 Based on the specific capture immobilization of 100 µg/mL biotinylated BSA in PBS (RG-SA pre-capture), with 1 µRIU corresponding approximately to 1 RU.

3 Based on the specific capture immobilization of 200 nM RG-SA on a RGD200M sensor chip.